Who is sponsoring NCT03526640?

NCT03526640 is sponsored by University Hospital, Akershus.

What drugs are being tested in NCT03526640?

Interventions in NCT03526640: The BioSentry Tract Sealant System.

What condition does NCT03526640 study?

NCT03526640 studies Computed Tomography, Biopsy, Pneumothorax, Chest Tube, Plug.

Is NCT03526640 still recruiting?

NCT03526640 is currently status unknown. Last updated 16 May 2018.

Last reviewed 2018-05-16 · How we verify

NCT03526640

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computed Tomography (CT) Guided Lung Biopsy With Plug

Status unknown NA Last updated 16 May 2018

What this trial tests

NA trial testing The BioSentry Tract Sealant System in Computed Tomography, Biopsy, Pneumothorax, Chest Tube, Plug in 560 participants. Status unknown.

Timeline

4 May 2018

Primary endpoint
4 August 2020

4 August 2023

Quick facts

Lead sponsor	University Hospital, Akershus
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	560
Start date	4 May 2018
Primary completion	4 August 2020
Estimated completion	4 August 2023
Sites	1 location across Norway

Drugs / interventions tested

The BioSentry Tract Sealant System

Conditions studied

Computed Tomography, Biopsy, Pneumothorax, Chest Tube, Plug — all drugs for Computed Tomography, Biopsy, Pneumothorax, Chest Tube, Plug →

Sponsor

University Hospital, Akershus

Who can join

18 and older, any sex, with Computed Tomography, Biopsy, Pneumothorax, Chest Tube, Plug. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Protocol Title: Computed Tomography (CT) Guided Lung Biopsy with BioSentry Plug, Evaluation of Safety and Efficacy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Akershus trials

Trials by the same sponsor.

NCT06865027 — The Effect of Arterial Carbon Dioxide Levels on Cerebral Blood Flow and Cerebral Autoregulation in the Steep Trendelenbu · NA · enrolling by invitation
NCT06721754 — Diabetes Related Foot Ulcers with Negative Pressure Wound Therapy · NA · recruiting
NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
NCT06576752 — Management of Patients with Heart Failure At Home After Hospital Discharge · NA · recruiting
NCT06032715 — Brief Intervention for Sleep Medication Misuse Among Elderly · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03526640 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Akershus
Last refreshed: 16 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing